Navigation Links
AEterna Zentaris Presents Phase 1 Results for AEZS-112 in Patients with Advanced Cancer and Lymphoma at AACR Annual Meeting in Denver
Date:4/22/2009

nd electrolyte loss at a dose of 200x3mg/week, no clinically relevant drug-related adverse events or changes in laboratory parameters were observed. AEZS-112 was shown to be metabolically stable in human plasma. As predicted by pharmacokinetic modelling based on data from part I of the study, the split-dose scheme leads to a higher Cmax and trough values after administration of comparable doses.

Conclusions

    - AEZS-112 was well tolerated over repeated treatment courses;
    - So far, a maximum tolerated dose for weekly dosing has not been
      defined; and
    - Prolonged courses of stable disease in both parts of the study are an
      encouraging observation.

About AEterna Zentaris Inc.

AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology, with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at www.aezsinc.com.

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of the Company to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional i
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
3. AEterna Zentaris Announces Outcome of Managements Strategic Review
4. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
7. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
8. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
9. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
10. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
11. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Sept. 15, 2014  FlexTech Alliance today issued ... printed product demonstrators (demos) and a functional electronic ... with pre-proposals due on October 22, 2014 and ... proposals ultimately selected are provided by the US ... cost share by the proposing organization. ...
(Date:9/15/2014)... fibers made of carbon nanotubes is neat, but Rice University ... carbon nanotubes in new fibers created at Rice line up ... by chemist Angel Mart and his colleagues. , The tricky ... month in the journal ACS Nano , is keeping ... a fiber. , Left to their own devices, carbon nanotubes ...
(Date:9/15/2014)... Zymo Research Corp., has announced the release ... ambient temperature storage and transport of infectious biological ... agents in such samples is completely inactivated by ... viral nucleic acids for subsequent analyses.  With the ... West Africa and the ...
(Date:9/15/2014)... AUSTIN, Texas , Sept. 15, 2014 The ... changes in climate, says a new article published by the ... Ahmed , PhD, on climate change and its effects on ... part of an extensive study conducted by Dr. Ahmed in ... China and has implications for the future ...
Breaking Biology Technology:FlexTech Alliance Issues 2015 Request for Proposals in Flexible, Printed Electronics 2Rice rolls 'neat' nanotube fibers 2Rice rolls 'neat' nanotube fibers 3Safe storage and transport of Ebola, Mers-CoV, and other viruses: Groundbreaking viral inactivation solution capable of preserving nucleic acids 2Safe storage and transport of Ebola, Mers-CoV, and other viruses: Groundbreaking viral inactivation solution capable of preserving nucleic acids 3Tea Taste and Quality Affected by Climate Change 2Tea Taste and Quality Affected by Climate Change 3Tea Taste and Quality Affected by Climate Change 4
... , CAMBRIDGE, Mass. , April 28 ... Research Awards Program.  Given annually, the awards will fund ... of diseases and other important human traits. To inaugurate ... interpretation services to three winning research groups, each of ...
... ... browsers enable researchers to quickly and effectively use these invaluable resources. , ... Seattle, WA (PRWEB) April 26, 2010 -- OpenHelix ... on the Overview of Genome Browsers. , , , Ensembl is a genome browser ...
... , LELYSTAD and ,S-HERTOGENBOSCH, The Netherlands ... based biotechnology firm focusing on,protein mimicking technology for the generation of ... therapeutic vaccine,portfolio with Immunovo BV of ,s-Hertogenbosch. Under the terms of ... a,minority interest in Immunovo. , ...
Cached Biology Technology:Knome Announces KnomeDISCOVERY Research Awards Program 2New and Updated Online Tutorials for Ensembl Legacy and Overview of Genome Browsers 2New and Updated Online Tutorials for Ensembl Legacy and Overview of Genome Browsers 3Pepscan Signs Partnering Agreement With Immunovo for its Therapeutic Vaccine Portfolio 2Pepscan Signs Partnering Agreement With Immunovo for its Therapeutic Vaccine Portfolio 3
(Date:9/16/2014)... RALEIGH, N.C. , Sept. 16, 2014  Valencell, ... has been chosen as one of 18 "Showcase Companies" ... technology businesses at the annual CED Tech Venture Conference ... Raleigh Convention Center in Raleigh, ... LeBoeuf will lead a discussion during the "Digital ...
(Date:9/16/2014)... season of bounty. Fungi of dizzying variety erupt from ... search of elusive but delectable wild mushrooms. Part of ... hunt, and their mysterious not-quite-meat, not-quite-vegetable qualities that belie ... you are eating known to science? , The Fungi ... some estimates range up to 10 million species, only ...
(Date:9/15/2014)... A published study indicates that lowland tapir populations may ... on hunting. Researchers from the Office National de ... Guiana and San Diego Zoo Global reviewed data retrieved ... the last four years and compared this data to ... were placed on hunting tapirs in French Guiana," said ...
Breaking Biology News(10 mins):Valencell, Inc. Selected as 'Showcase Company' at CED Tech Venture Conference 2014 2What's for dinner? Rapidly identifying undescribed species in a commercial fungi packet 2What's for dinner? Rapidly identifying undescribed species in a commercial fungi packet 3
... published online in the open-access journal PLoS Pathogens, Dr. ... colleagues identify new host species for avian influenza A ... between the ecology and epidemiology of various global strains ... included more than 36,000 wild migratory birds tested for ...
... of Missouri-Columbia has discovered a way to create engineered ... This discovery opens new possibilities for the development of ... bacteria and herbicides, and for the development of proteins ... illnesses. , In a paper published in the Proceedings ...
... genetic adaptations in the nematode Acrobeloides nanus. The ... more eggs under polluted conditions than the worms ... this in her study into the long-term effects ... Environmental pollution is an important cause of stress ...
Cached Biology News:Researchers attach genes to minichromosomes in maize 2Asexual worm quickly adapts to soil contamination 2
Presenilin-1, N-terminus....
Request Info...
Human DEP-1/CD148 Fluorescein MAb (Clone 143-41) Protein Family: Granulocyte Markers, Monocyte Markers, Phosphatases & Regulators, Other Dendritic Cell Molecules...
An excellent carbonyl-reactive FRET quencher paired with Trp or Tyr. Minimum Purity: 95%. Abs(max): ~350 nm; Em(max): none. Solvent System:DMSO or DMF....
Biology Products: